Pain, Post-operative Clinical Trial
Official title:
Prospective, Observational Study With a Multimodal Analgesic Protocol to Moderate Acute Pain After Third Molar Surgery
NCT number | NCT03456141 |
Other study ID # | 18-0047 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | March 1, 2018 |
Est. completion date | December 31, 2022 |
Verified date | December 2022 |
Source | University of North Carolina, Chapel Hill |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
With a prospective, observational study assess post-surgery pain levels and patient's use of opioids and other analgesic drugs to moderate pain following third molar surgery.
Status | Completed |
Enrollment | 100 |
Est. completion date | December 31, 2022 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - ASA I,II At least two lower 3rd molars scheduled for removal Exclusion Criteria: - Patient being treated for opioid addiction/abuse including having Rx for suboxone, methadone |
Country | Name | City | State |
---|---|---|---|
United States | University of North Carolina School of Dentistry | Chapel Hill | North Carolina |
Lead Sponsor | Collaborator |
---|---|
University of North Carolina, Chapel Hill |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The impact of the surgery on the patient's post-surgery pain. | Likert scales for average pain and worst pain are assessed with 7-point scales with verbal anchors of "no pain" and "worst pain imagined".
Recovery for pain on the Likert scales is defined as the number of PSD until the patient reports a score of 1 or 2 on the 7-point scale. |
14 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02284243 -
Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery
|
Phase 2 | |
Completed |
NCT02720692 -
Evaluation of N1539 Following Major Surgery
|
Phase 3 | |
Terminated |
NCT02169336 -
Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy
|
Phase 2 | |
Not yet recruiting |
NCT05950152 -
Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery
|
Phase 2 | |
Completed |
NCT02675907 -
Evaluation of N1539 Following Bunionectomy Surgery
|
Phase 3 | |
Completed |
NCT02678286 -
Evaluation of N1539 Following Abdominoplasty Surgery
|
Phase 3 | |
Unknown status |
NCT01041313 -
Memantine for Post-Operative Pain Control
|
Phase 4 | |
Completed |
NCT02540265 -
Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery
|
Phase 2 | |
Completed |
NCT03154658 -
Serratus Anterior Plane Block in Patients Undergoing Mastectomy
|
Phase 4 |